Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shakila Meshkat

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Affective Disorders|September 19, 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic reviewGia Han Le, Sabrina Wong, Andy Lu, et al.
Journal of Affective Disorders|June 20, 2024
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysisDonovan A Dev, Gia Han Le, Angela T H Kwan, et al.
World Neurosurgery|December 24, 2023
Anxiety and Depression in Pediatric-Onset Traumatic Spinal Cord Injury: A Systematic ReviewMohammad Mofatteh, Mohammad Sadegh Mashayekhi, Saman Arfaie, et al.
Annals of General Psychiatry|February 29, 2024
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetineAngela T H Kwan, Gia Han Le, Ziji Guo, et al.
CNS Spectrums|October 21, 2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophreniaMuhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
Acta Neuropsychiatrica|April 12, 2024
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.
Advances in Therapy|March 23, 2024
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on VortioxetineAngela T H Kwan, Ziji Guo, Felicia Ceban, et al.
Current Medical Research and Opinion|June 11, 2024
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysisKayla M Teopiz, Angela T H Kwan, Gia Han Le, et al.
Clinical Nursing Research|April 15, 2025
Impact of Fatigue on Subjective and Objective Cognitive Functions in Persons with Post-COVID-19 ConditionGia Han Le, Angela T H Kwan, Ziji Guo, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Affective Disorders|September 19, 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic reviewGia Han Le, Sabrina Wong, Andy Lu, et al.
Journal of Affective Disorders|June 20, 2024
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysisDonovan A Dev, Gia Han Le, Angela T H Kwan, et al.
World Neurosurgery|December 24, 2023
Anxiety and Depression in Pediatric-Onset Traumatic Spinal Cord Injury: A Systematic ReviewMohammad Mofatteh, Mohammad Sadegh Mashayekhi, Saman Arfaie, et al.
Annals of General Psychiatry|February 29, 2024
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetineAngela T H Kwan, Gia Han Le, Ziji Guo, et al.
CNS Spectrums|October 21, 2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophreniaMuhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
Acta Neuropsychiatrica|April 12, 2024
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.
Advances in Therapy|March 23, 2024
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on VortioxetineAngela T H Kwan, Ziji Guo, Felicia Ceban, et al.
Current Medical Research and Opinion|June 11, 2024
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysisKayla M Teopiz, Angela T H Kwan, Gia Han Le, et al.
Clinical Nursing Research|April 15, 2025
Impact of Fatigue on Subjective and Objective Cognitive Functions in Persons with Post-COVID-19 ConditionGia Han Le, Angela T H Kwan, Ziji Guo, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.
Pageof 9